Carlos Villa Joins Versiti Blood Research Institute
Versiti Blood Research Institute shared on LinkedIn:
”Please welcome Carlos Villa, MD, PhD to VBRI!
Carlos Villa is joining the Translational Hematology Program as a Transfusion Medicine Clinician Investigator.
He joins Versiti from the US Food and Drug Administration where, most recently, he was the Associate Director for Special Programs in the Office of Blood Research and Review at CBER.
In that role, he contributed to regulatory, policy, and research initiatives to advance the safety and effectiveness of blood and blood components.
His clinical background is in Clinical Pathology and Transfusion Medicine, and his research has spanned basic sciences to clinical medicine, with experience in pharmacology and drug delivery.
He completed his MD/PhD training at the Tri Institutional program at Weill Cornell and Memorial Sloan Kettering, which was followed by residency and fellowship training at the University of Pennsylvania.”
Stay updated with Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?